GGrantIndex
Sort

51,593 grants matching hepatitis

Prevalence and Prognosis of Pulmonary Hypertension in Adults with Sickle Cell

$371,912
James Taylor · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL

Hepatocellular Transport of Biliary Phospholipids

$371,886
David E Cohen · Brigham And Women'S Hospital · R01 · FY2006 · DK

ALTERED METHIONINE METABOLISM IN ALCOHOLIC LIVER INJURY

$371,881
University Of Southern California · R01 · FY2005 · AA

Harnessing big data to arrest the HIV/HCV/opioid syndemic in the rural and urban South

$371,875
Peter F Rebeiro · Vanderbilt University Medical Center · R01 · FY2023 · DA

Harnessing big data to arrest the HIV/HCV/opioid syndemic in the rural and urban South

$371,875
Peter F Rebeiro · Vanderbilt University Medical Center · R01 · FY2024 · DA

Harnessing big data to arrest the HIV/HCV/opioid syndemic in the rural and urban South

$371,875
Peter F Rebeiro · Vanderbilt University Medical Center · R01 · FY2025 · DA

ErbB Signaling in Liver Ontogeny and Regeneration

$371,838
Vanderbilt University · R01 · FY2003 · DK

The Logics for HIV Risk Among Homeless Heroin Injectors

$371,809
University Of California San Francisco · R01 · FY2004 · DA

Proteomic Analysis of Serum in Liver Cancer

$371,802
Radoslav Goldman · Georgetown University · R01 · FY2007 · CA

Role of heat shock protein 90 in alcoholic liver disease

$371,773
Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2012 · AA

Role of heat shock protein 90 in alcoholic liver disease

$371,773
Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2011 · AA

Regulation of Hepatic Gluconeogenesis by the Mitochondrial Pyruvate Carrier

$371,737
Eric B Taylor · University Of Iowa · R01 · FY2017 · DK

A TRIAL TO REDUCE HEPATITIS C AMONG INJECTION DRUG USERS

$371,720
Rhode Island Hospital (Providence, Ri) · R01 · FY2003 · DA

Harvard Hepatitis B Consortium

$371,677
Daryl T Lau · Beth Israel Deaconess Medical Center · U01 · FY2019 · DK

Task A19 HUMAN HEPATITIS B VIRUS (HBV) MOUSE MODELS FOR TESTING HBV THERAPEUTICS

$371,637
Norman Kneteman · Utah State University · N01 · FY2013 · AI

Lipid Aldehydes and Ethanol Induced Liver Damage

$371,599
University Of Colorado Denver · R01 · FY2001 · AA

HEPATIC ORGANIC ANION UPTAKE AND TRANSPORT

$371,589
Yeshiva University · R01 · FY2002 · DK

New Antiviral Therapies for Hepatitis C Infection

$371,584
Thomas C Hermann · University Of California, San Diego · R01 · FY2007 · AI

Clinical Research Network in NASH

$371,577
Nathan M Bass · University Of California, San Francisco · U01 · FY2008 · DK

Cu homeostasis by the Cu-ATPase, ATPase, ATP7B in Polarized Hepatic Cells

$371,560
Ann Hubbard · Johns Hopkins University · P01 · FY2009 · DK

HBV RNaseH inhibitors: Effects on HBV biology and resistance development

$371,540
John E Tavis · Saint Louis University · R01 · FY2020 · AI

Leptin Treatment of HIV-Associated Lipodystrophy

$371,536
University Of California San Francisco · R01 · FY2003 · DK

Ultra-Low Background NIR Fluorophores for In Vivo Imaging and Image-Guided Surger

$371,532
John V Frangioni · Curadel, Llc · R01 · FY2013 · EB

Gene Therapy for Hemophilia Using Muscle-Expressed FVIIa

$371,508
Katherine A High · Children'S Hosp Of Philadelphia · P01 · FY2011 · HL

Michigan Hepatotoxicity Clinical Research Network Renewal 2013

$371,508
Robert J Fontana · University Of Michigan At Ann Arbor · U01 · FY2014 · DK